Depression

Systemically administered hormonal therapy may be associated with a greater risk of depression before and during menopause.

Experts discuss the clinical and economic impact of misdiagnosing bipolar I disorder as major depressive disorder.

New research finds that mental health has replaced COVID-19 as the top health concern among Americans, but deeper analysis needs to be done into whether depression and anxiety are truly becoming more widespread.

New research about the risks of dementia in patients with non-affective psychotic disorders could help shape new life course models for prevention.

The research further supports zuranolone as a potential episodic treatment for people with MDD, according to the study authors.

Pregnant women with epilepsy showed more symptoms of anxiety and depression than healthy pregnant or non-pregnant women, but mental health screening may help.

Routine depression screening in the primary care setting lowered screening disparities and increased recognition of symptoms for groups at risk of undertreatment, including racial and ethnic minority individuals and patients of older age.

A systematic review of literature found that family history of psychiatric disorders is a risk factor associated with postpartum depression, adding to a contradictory body of research.

Abbott will work with the FDA to expedite the review of their deep brain stimulation system to treat the life-threatening disease of treatment-resistant depression.

Transgender children were more susceptible to depression, anxiety, and other mental health issues than their cisgender counterparts.

Participants took about 50 times higher than the recommended daily allowance every day for a month, investigators say

A review of decades of research concluded that there is no evidence of an association between serotonin levels and depression, calling the function of antidepressants into question.

Appropriate screening tools can help identify individuals at increased risk for or with anxiety, depression, and eating disorders.

The medications are linked with reduced negative emotional bias, according to new research published in Biological Psychiatry.

More than half of women diagnosed with anxiety and/or depression said they waited at least 1 year before seeking treatment, or never sought treatment at all.

Studies have estimated that 16% of people with dementia experience depression, but this may be as high as 40%, demonstrating a great need for effective treatments.

Larger increases were typically seen in states with fewer deaths related to COVID-19, lower unemployment among women, analysis finds.

The companies expect to complete the submission to the FDA for MDD in the first half of 2022 and an associated filing for postpartum depression in 2023.

Depression can make people who have recovered from COVID-19 feel less enthusiastic in their daily lifestyle.

When states legalize marijuana, the volume of prescriptions within the drug classes that align with the medical indications for pain, depression, anxiety, sleep, psychosis, and seizures significantly decline.

Analysis indicates that factors associated with psychological flourishing include being married and physically active, as well as free from chronic pain and anxiety and depression.

Evidence indicates that low-dose tramadol is a generally safe, effective, and fast-acting antidepressant for a substantial number of individuals suffering from depression.

Mindfulness-based cognitive therapy helps change feelings and thoughts about experiences, minimizing depressive episodes, analysis indicates.

Analysis to be presented at the American College of Cardiology’s 71st Annual Scientific Session is based on the health records of 495,386 patients.

Most other compounds undergoing clinical trials target testosterone, which can lead to depression, higher low-density lipoprotein cholesterol levels, and weight gains.

Thirty minutes of day of movement, such as walking, can help break the cycle of inflammation that causes symptoms even 6 months later.

The commission “Time for United Action on Depression,” authored by 25 experts from 11 countries, seeks to unify global efforts among governments, health care providers, researchers, people living with depression, and their families to improve care and prevention, fill knowledge gaps, and increase awareness.

In a phase 3 study, there were clinically and statistically significant changes observed from baseline to week 6 in the Montgomery-Åsberg Depression Rating Scale (MADRS) total score for patients treated with cariprazine at 1.5 mg/day versus the placebo.